Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 5:19418744251367181.
doi: 10.1177/19418744251367181. Online ahead of print.

Reversible Diffusion-Restricting White Matter Lesions in Sickle Cell Disease During Pain Crises: A Case Report

Affiliations
Case Reports

Reversible Diffusion-Restricting White Matter Lesions in Sickle Cell Disease During Pain Crises: A Case Report

Sangharsha Thapa et al. Neurohospitalist. .

Abstract

Sickle cell disease (SCD) is a chronic hemoglobinopathy characterized by recurrent vaso-occlusive events and significant neurological morbidity. While ischemic and hemorrhagic strokes are well-known complications, reversible diffusion-restricting white matter lesions are exceedingly rare and underreported. We present the case of an 18-year-old male with homozygous SCD (HbSS) who developed acute neurological deterioration during a vaso-occlusive pain crisis. MRI revealed symmetric areas of restricted diffusion and FLAIR hyperintensities in the splenium of the corpus callosum and periventricular white matter, typically associated with cytotoxic edema and irreversible injury. Remarkably, the patient experienced near-complete neurological recovery with aggressive disease-targeted therapy, including hydroxyurea, voxelotor, and serial exchange transfusions. Follow-up MRI at 4 months showed complete resolution of the prior abnormalities. This case underscores the importance of recognizing potentially reversible diffusion-restricting lesions in SCD and challenges the conventional interpretation of restricted diffusion as a marker of permanent injury. Early recognition, comprehensive management, and serial neuroimaging may improve neurological outcomes in similar cases. Clinicians should maintain a high index of suspicion for reversible white matter injury when evaluating patients with sickle cell disease presenting with acute neurological symptoms. Incorporating serial neuroimaging and a multidisciplinary treatment approach is essential for timely diagnosis and optimizing neurological recovery in this vulnerable population.

Keywords: cytotoxic edema; diffusion-weighted imaging; encephalopathy; exchange transfusion; hydroxyurea; periventricular white matter; reversible white matter lesions; sickle cell disease; splenium; vaso-occlusive crisis; voxelotor.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
MRI brain imaging obtained during acute illness (top row) and at 4-month follow-up (bottom row), including diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC), and FLAIR sequences. Initial imaging demonstrates symmetric restricted diffusion and T2 hyperintensities in the splenium and periventricular white matter (Panels A-C). Follow-up imaging shows complete resolution of these abnormalities, consistent with reversible white matter injury (Panels D-F).

Similar articles

References

    1. DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829-838. - PubMed
    1. Al-Jafar HA, Alroughani R, Abdullah TA, Al-Qallaf F. Neurological complications in sickle cell disease. Int J Clin Exp Neurol. 2016;4(1):9-18.
    1. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019;14(1):263-292. - PMC - PubMed
    1. DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587-4596. - PMC - PubMed
    1. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the cooperative study of sickle cell disease. AJNR Am J Neuroradiol. 1996;17(5):965-972. - PMC - PubMed

Publication types

LinkOut - more resources